Case Report

Vol. 33 No. 3 (2018): The Archives of Rheumatology
DOI: https://doi.org/10.5606/ArchRheumatol.2018.6668

Article Sidebar

PDF HTML
Published: Sep 30, 2018
Keywords:
Intestinal perforation; pneumatosis intestinalis; tocilizumab
How to Cite
Ben JACOBS, Ali JAWAD, & Zozik FATTAH. (2018). Pneumatosis Intestinalis and Intestinal Perforation in a Patient Receiving Tocilizumab. Archives of Rheumatology, 33(3), 372–375. https://doi.org/10.5606/ArchRheumatol.2018.6668

Main Article Content

Ben JACOBS
Department of Rheumatology, Barts Health NHS Trust, London, United Kingdom
Ali JAWAD
Department of Rheumatology, Barts Health NHS Trust, London, United Kingdom
Zozik FATTAH
Department of Rheumatology, Barts Health NHS Trust, London, United Kingdom

Pneumatosis Intestinalis and Intestinal Perforation in a Patient Receiving Tocilizumab

Main Article Content

Ben JACOBS
Department of Rheumatology, Barts Health NHS Trust, London, United Kingdom
Ali JAWAD
Department of Rheumatology, Barts Health NHS Trust, London, United Kingdom
Zozik FATTAH
Department of Rheumatology, Barts Health NHS Trust, London, United Kingdom

Abstract

In this article, we report a case of pneumatosis intestinalis associated with tocilizumab use. This is a unique case and may explain the increased rate of idiopathic bowel perforation among patients taking tocilizumab.

Article Details

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.